ClinicalTrials.gg
RecruitingNCT06511583FBS-ASaPUpdated Jul 22, 2024

FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department

An observational study in Aspiration Pneumonia and Bronchoscopy, sponsored by Azienda Ospedaliero-Universitaria Careggi. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.

Sponsored by Azienda Ospedaliero-Universitaria Careggi · Observational

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Non-Profit Prospective Observational Pilot Study

The study will have an overall duration of 3 years, with patient enrollment starting after ethical committee approval.

In this study, all patients with a diagnosis of aspiration pneumonia who require aspiration of secretions or ingesta in the Emergency Department will be considered. A registry will be created with the patients\' data, noting the type of procedure performed: laryngotracheal aspiration with a probe or with fibrobronchoscopy.

This observational registry pilot study aims to evaluate the utility and adverse events related to the use of aspiration via videobronchoscopy performed in the Emergency Department and to compare the clinical outcomes of patients undergoing bronchoscopy with those treated only with blind laryngotracheal aspiration using a probe.

02

Conditions studied

  • Aspiration Pneumonia
  • Bronchoscopy

Keywords

  • Aspiration pneumonia
  • Bronchoscopy
  • toilette
  • interventional pulmunology
  • respiratory failure
  • pneumonia
  • bacterial pneumonia
03

In context

Pneumonia, Aspiration

73 studies on the registry are indexed under Pneumonia, Aspiration; 12 are open to participants now.

This study's planned enrollment of 100 is close to the median of 93 across 28 observational studies indexed under Pneumonia, Aspiration.

Browse Pneumonia, Aspiration studies →

Lead sponsor

Azienda Ospedaliero-Universitaria Careggi is the lead sponsor of 78 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study will be conducted on patients with a diagnosis of aspiration pneumonia who, based on the judgment of the attending physician, require aspiration of secretions or ingesta in the emergency department using a probe and/or a fiberscope. Enrollment in the study will be determined by the Emergency Department physician in charge of the patient.

Estimated number of patients to be enrolled: 100.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All adult patients who access the Emergency Department with a diagnosis of aspiration pneumonia and for whom the referring physician determines the need for aspiration of secretions or ingesta. Patients must have at least one of the following criteria

  • Radiological evidence of pneumonia (Chest X-ray/CT scan/Chest ultrasound)
  • Clinical diagnosis of aspiration pneumonia
  • Presence of secretions in the upper airways
  • Respiratory distress in a dysphagic patient
  • Need for oxygen therapy or need to increase FiO2 in patients already on home oxygen therapy

Exclusion criteria

Exclusion Criteria:

  • Lack of consent
  • Age \< 18 years
  • Pregnancy
  • Hemorrhagic diathesis
  • Malignant cardiac arrhythmias (VT, AV block excluding first-degree AV block)
  • Severe airway obstruction
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

    Patients with aspiration pneumonia. For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient's head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.

    Procedure: Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

  • Aspiration Using Fibrobronchoscopy in the Emergency Department

    Patients with aspiration pneumonia. The bronchoscope will be gently inserted through the patient's nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.

    Procedure: Aspiration Procedure Using Fibrobronchoscopy in the Emergency Department

Interventions

  • ProcedureLaryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

    For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient\'s head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.

  • ProcedureAspiration Procedure Using Fibrobronchoscopy in the Emergency Department

    Equipment Setup: A sterile bronchoscope will be connected to the suction apparatus. Procedure: The bronchoscope will be gently inserted through the patient\'s nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.

06

What researchers measure

Primary outcomes

  1. Length of hospital stay in days

    Length of hospital stay in days

    Time frame: up to 3 months

  2. Mortality rate within 30 days from the time of admission to the Emergency Department

    Mortality rate within 30 days from the time of admission to the Emergency Department

    Time frame: 30 days from admission to the ed

Secondary outcomes

  1. Respiratory parameters before and after the procedure

    (SpO2, FiO2)before and after the procedure

    Time frame: on the admission and 30 minutes after the procedure

  2. Rate of patient treated with Non invase ventilation and with orotracheal intubation

    Oxygen therapy devices before and after the procedure

    Time frame: on the admission and 30 minutes after the procedure

  3. Rate of admission in Intensive care unit and High dependency unit

    Hospitalization setting

    Time frame: immediately after the procedure

  4. Procedure-related complications

    Procedure-related complications

    Time frame: perioperatively/periprocedurally

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for Feb 2027, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2024
First posted
Jul 22, 2024
StartActual
Feb 5, 2024
Primary completionEst.
Feb 5, 2027
CompletionEst.
Mar 5, 2027
Last update
Jul 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06511583
Lead sponsor
Azienda Ospedaliero-Universitaria Careggi
Responsible party
Peiman Nazerian (Principal Investigator, Azienda Ospedaliero-Universitaria Careggi) — Principal investigator
First posted
Jul 22, 2024
Start date
Feb 5, 2024
Primary completion
Feb 5, 2027 (estimated)
Completion
Mar 5, 2027 (estimated)
Last update
Jul 22, 2024

Study contacts

Lorenzo Pelagatti, Dr
Contact
pelagattil@aou-careggi.toscana.it
+393385917317
Pelagatti Lorenzo, Dr
Contact
lorenzo.pelagatti@unifi.it
+390557947088
Lorenzo Pelagatti, dr
principal investigator · University of Florence

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion